The panel expressed concerns about the proposed doses of Blenrep (belantamab mafodotin) in GSK's marketing application, ...

GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...

By Sanchayaita Roy (Reuters) -European shares rose on Friday, boosted by gains in Vestas and Saab, while investors focused on ...

Indian benchmark indices Sensex and Nifty traded lower on Friday, dragged by declines in Axis Bank, Bharti Airtel, and Kotak ...